← All news
Tech

Cambridge Cognition (LSE:COG) joins a dementia diagnosis push this week: where does digital testing fit in AI-era healthcare?

1 source ·1 article ·1h ago

Highlights Cambridge Cognition launched a UK Alzheimer's diagnosis pathway with C2N Diagnostics and The Alzheimer's Trust. The pathway combines a blood test, the CANTAB Pathway digital assessment and access to scans. Interim results showed…

Covered by 1 outlet

All coverage · 1 article